Stay updated on Elranatamab Combo vs Daratumumab Combo in MM Clinical Trial
Sign up to get notified when there's something new on the Elranatamab Combo vs Daratumumab Combo in MM Clinical Trial page.

Latest updates to the Elranatamab Combo vs Daratumumab Combo in MM Clinical Trial page
- Check2 days agoChange DetectedBeijing, China (Beijing Municipality) with Peking Union Medical College Hospital was added; Genova, Italy added IRCCS Azienda Ospedaliera Metropolitana (IRCCS AOM). Removed entries include Beijing Peking Union Medical College Hospital and Genoa-related sites such as Ospedale San Martino and Liguria, with the total study locations changing to 238.SummaryDifference0.5%

- Check9 days agoChange DetectedAdded related topics 'Multiple myeloma' and 'MedlinePlus Genetics'. Updated the page revision from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedFooter revision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check30 days agoChange DetectedNo additions or deletions detected on the page.SummaryDifference0.0%

- Check37 days agoChange DetectedRemoved references to multiple myeloma and related MedlinePlus Genetics topics from the page.SummaryDifference0.0%

- Check44 days agoChange DetectedAdded 'Multiple myeloma' as a related topic and included 'MedlinePlus Genetics'; updated page revision from v3.4.1 to v3.4.2.SummaryDifference0.1%

Stay in the know with updates to Elranatamab Combo vs Daratumumab Combo in MM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Elranatamab Combo vs Daratumumab Combo in MM Clinical Trial page.